Stallergenes wins U.S. go-ahead for Oralair allergy pill
CHICAGO/PARIS (Reuters) - France's Stallergenes has received U.S. regulatory approval to sell the first immunotherapy pill against grass allergies in ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/qI1H2546au8/story01.htm
No comments:
Post a Comment